Frazier Life Sciences IX L.P. 13D and 13G filings for Mirum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-09-05 3:11 pm Purchase |
2023-08-31 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Frazier Life Sciences IX L.P. | 6,226,392 13.400% |
1,815,285 (+41.15%) |
Filing |
| 2023-04-14 12:45 pm Purchase |
2023-04-12 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Frazier Life Sciences IX L.P. | 4,411,107 11.600% |
549,326 (+14.22%) |
Filing |
| 2022-08-16 12:20 pm Purchase |
2022-08-12 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Frazier Life Sciences IX L.P. | 3,861,781 10.500% |
294,869 (+8.27%) |
Filing |
| 2020-12-18 12:40 pm Unchanged |
2020-12-17 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Frazier Life Sciences IX L.P. | 3,566,912 12.200% |
0 (Unchanged) |
Filing |
| 2020-04-29 4:36 pm Unchanged |
2020-01-13 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Frazier Life Sciences IX L.P. | 3,566,912 14.000% |
0 (Unchanged) |
Filing |